eribulin mesylate
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
23 FDA-registered drug labelers
Apotex Corp.
Baxter Healthcare Company
BluePoint Laboratories
BSP Pharmaceuticals SpA
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chongqing Biocare Pharmaceutical Ltd.
Chongqing Sintaho Pharmaceutical Co., Ltd.
Dr. Reddys Laboratories Inc
Dr. Reddys Laboratories Limited
Eisai Co., Ltd.
Eisai Inc.
Emcure Pharmaceuticals Limited
Formosa Laboratories, Inc.
Gland Pharma Limited
GLENMARK PHARMACEUTICALS INC., USA
HIKMA PHARMACEUTICALS USA INC.
Kindos Pharmaceuticals Co., Ltd.
Lianyungang Runzhong Pharmaceutical Co., Ltd.
Long Grove Pharmaceuticals, LLC
Northstar Rx LLC
Sandoz Inc
Sun Pharmaceutical Industries Limited
Wisdom Pharmaceutical Co.,Ltd.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Eribulin Mesylate
- •Halaven
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS441045-17-6
PubChem CID17755248
DTXSIDDTXSID401381388
FormulaC41H63NO14S
Mol. Weight826 g/mol
SMILESCC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O.CS(=O)(=O)O
Data Sources
177552482026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/eribulin mesylate/cids/JSON
Archive: data/sources/pubchem_name/eribulin mesylate.json
CAS 441045-17-62026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json